Summary
A micromethod is described for determination of the cytochrome P-450 content, demethylation rate of aminopyrine and p-nitroanisole, the activities of NADPH-cytochrome-c-reductase, pseudocholinesterase and glucose-6-phosphatase in homogenates of the small amount of human liver (about 20 mg) obtained by needle biopsy. 1 g of human liver contains 32–38 mg microsomal protein, much less than that present in rat liver (50–60 mg/g liver). The cytochrome P-450 content in normals was 10.8±2.6 nmoles/g liver wet weight (mean±1 S.D.). In severe hepatitis and cirrhosis the cytochrome P-450 content fell to 50% of the control value, whereas mild and moderate hepatitis did not produce any change. Similarly, only in seriously damaged livers were the demethylationrates of both substrates lowered. The activity of the NADPH-cytochrome-c-reductase was 1.88±0.51 micromoles/g liver × min and was not impaired even by severe liver damage. The activities of glucose-6-phosphatase and pseudocholinesterase also fell only in severe liver disease.
Similar content being viewed by others
References
Ackermann, E., Heinrich, I.: Die Aktivität der N- und O- Demethylase in der Leber des Menschen. Biochem. Pharm.19, 327–342 (1970).
—— Die Demethylierung von Aminophenazon und Codein in der Leber des Menschen. Biochem. Pharm.19, 1955–1973 (1970).
Alexanderson, B., Price Evans, D.A., Sjöqvist, F.: Steadystate plasma levels of nortriptyline in twins: Influence of genetic factors and drug therapy. Brit. med. J.1969 IV, 764–768.
Alvarez, A.P., Schilling, G., Levin, W., Kuntzman, R., Brand, L., Mark, L.: Cytochrome P-450 and b-5 in human liver microsomes. Clin. Pharm. and Therap.10, 655–659 (1969).
Brodie, B.B.: Physiological disposition and chemical fate of thiobarbiturates in the body. Fed. Proc.11, 632–639 (1952).
—— Axelrod, J.: The fate of antipyrine in man. J. Pharm. Baltimore98, 97–104 (1950).
—— —— The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J. Pharm. Baltimore99, 171–184 (1950).
—— Bruns, J.J., Weiner, M.: Metabolism of drugs in subjects with Laennec's cirrhosis. Med. Exp.1, 290–292 (1959).
Butler, T.C., Mahaffe, C., Wadell, C.W.: Phenobarbital: Studies of elimination, accumulation, tolerance and dosage schedules. J. Pharm. exp. Therap.111, 425–435 (1954)
Darby, F.J., Newnes, W., Price Evans, D.A.: Human liver microsomal drug metabolism. Biochem. Pharm.19, 1514–1517 (1970).
Greim, H.: Synthesesteigerung und Abbauhemmung bei der Vermehrung der mikrosomalen Cytochrome P-450 und b-5 durch Phenobarbital. Naunyn Schmiedebergs Arch. Pharmak.266, 261–275 (1970).
Griffin, C.C., Waradekar, V.S., Tramp, B.F., Goldblatt, P.J., Stowell, R.E.: Studies on necrosis on mouse liver. Amer. J. Path.47, 833–850 (1965).
Harper, A.E.: Glucose-6-phosphatase. In Bergemeyer: Methoden der enzymatischen Analyse. S. 788–792. Weinheim: Verlag Chemie 1962.
Held, V., v. Oldershausen, H.F.: Zur Pharmakokinetik von Meprobamat bei chronischen Hepatopathien und Arzeneimittelsucht. Klin. Wschr.47, 78–80 (1969).
—— —— Remmer, H.: Der Abbau von Pentobarbital bei Leberschäden. Klin. Wschr.48, 565–567 (1970).
Heni, N., Remmer, H.: Die Wirkung von Tetrachlorkohlenstoff auf endoplasmatische Enzyme der Rattenleber. Arch. Toxicol.28, 1–11 (1971).
Kommerell, B., Franken, F.H.: Über die Serumcholinesteraseaktivität bei Lebererkrankungen. Dtsch. med. Wschr.81, 1959–1961 (1956).
Kunin, C., Anthony, M., Glazko, J., Finland, M.: Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis. J. clin. Invest.38, 1498–1508 (1959).
Levi, A.J., Sherlock, S., Walker, D.: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet1968 II, 1275–1279.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randal, R.J.: Protein measurement with the folin phenol reagent. J. biol. Chem.193, 265–275 (1951).
Massey, V.: The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim. Biophys. Acta34, 255–256 (1959).
Nash, T.: The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J.55, 416–421 (1953).
Netter, K.J., Seidel, G.: An adaptively stimulated O-demethylating system in rat liver microsomes and its kinetic properties. J. Pharm. exp. Therap.146, 61–65 (1964).
Omura, T., Sato, R.: The carbon monoxide — binding pigment of liver. J. biol. Chem.239, 2370–2378 (1964).
Preisig, R.: Beurteilung der alkoholischen Zirrhose nach hämodynamischen und funktionellen Gesichtspunkten: Alcohol and the liver, p. 329–331. International Symposion, October 2–4, 1970 Freiburg, Germany. Stuttgart-New York: F.K. Schattauer Verlag 1971.
Quinn, C.P., Axelrod, J., Brodie, B.B.: Species, strain, and sex differences in metabolism of hexobarbitone amidopyrine, antipyrine and aniline. Biochem. Pharm.1, 152–159 (1958).
Raj, P., Nelson, E.B., Estabrook, R.W.: Studies on drug metabolism in human liver. Chemico-Biol. Interact.3, 303–304 (1971).
Remmer, H.: Die Standardisierung des roten Blutfarbstoffs durch Hämiglobincyanid. II. Mitteilung. Arch. exper. Path. und Pharm.229, 450–462 (1956).
-- Estabrook, R.W., Schenkman, J., Greim, H.: Induction of microsomal liver enzymes. In: Enzymatic oxidations of toxicants. North Carolina State University of Raleigh. Library of Congress. Catalog card Number 68–63 363 (1968) p. 65–88.
—— Hirschmann, J., Greiner, I.: Die Bedeutung von Kumulation und Elimination für die Dosierung von Phenytoin (Diphenylhydantoin). Dtsch. med. Wschr.94, 1265–1272 (1969).
Schmidt, E., Schmidt, F.W., Wildhirt, E.: Ferment-aktivitätsbestimmungen in der menschlichen Leber. VI. Mitteilung. Klin. Wschr.37, 1221–1229 (1959).
Schenkman, J.B., Frey, I., Remmer, H., Estabrook, R.W.: Sex differences in drug metabolism by rat liver microsomes. Molec. Pharm.3, 516–525 (1967).
Schoene, B., Remmer, H.: to be published.
Thorgeirsson, S.S., Davies, D.S.: Kinetic studies of the N-demethylation of ethylmorphine by a cytochrome P-450 dependent system in human liver microsomes. Int. Sympos. on Drug metabolism. Skokloster, Sweden June 2–4 (1971).
Vesell, E.S., Page, J.G.: Genetic control of drug levels in man: phenylbutazone. Science159, 1479–1480 (1968).
—— —— Genetic control of drug levels in man: antipyrine. Science161, 72–73 (1968).
—— —— Passananti, G.Th.: Genetic and environmental factors affecting ethanol metabolism in man. Clin. Pharm. and Therap.12, 192–201 (1971).
Weber, H.: Rasche und einfache Ultramikromethode zur Bestimmung der Serumcholinesterase. Dtsch. med. Wschr.91, 1927–1932 (1966).
Williams, Ch.H., Kamin, H.: Microsomal triphosphopyridine nucleotide-cytochrome-c-reductase of liver. J. biol. Chem.237, 587–595 (1962).
Williams, R.: Clinical implications of hepatic enzyme induction. 13th Meeting of the European Society for the Study of Drug Toxicity Berlin, Germany June 7–9 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schoene, B., Fleischmann, R.A., Remmer, H. et al. Determination of drug metabolizing enzymes in needle biopsies of human liver. Eur J Clin Pharmacol 4, 65–73 (1972). https://doi.org/10.1007/BF00562499
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00562499